Cargando…

miR-381-3p suppresses breast cancer progression by inhibition of epithelial–mesenchymal transition

BACKGROUND: Accumulating evidence indicates that miRNAs are involved in multiple cellular functions and participate in various cancer development and progression, including breast cancer. METHODS: We aimed to investigate the role of miR-381-3p in breast cancer. The expression level of miR-381-3p and...

Descripción completa

Detalles Bibliográficos
Autores principales:	Yu, Yong-Zheng, Mu, Qiang, Ren, Qian, Xie, Li-Juan, Wang, Qi-Tang, Wang, Cui-Ping
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2021
Materias:	Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8348871/ https://www.ncbi.nlm.nih.gov/pubmed/34362391 http://dx.doi.org/10.1186/s12957-021-02344-w

Ejemplares similares

Periostin promotes epithelial-mesenchymal transition via the MAPK/miR-381 axis in lung cancer
por: Hu, Wei-Wei, et al.
Publicado: (2017)

miR-381-3p Involves in Glioma Progression by Suppressing Tumor-Promoter Factor ANTXR1
por: Dong, Zhiqiang, et al.
Publicado: (2021)

miR-665 Suppresses the Epithelial–Mesenchymal Transition and Progression of Gastric Cancer by Targeting CRIM1
por: Wu, Kun-Zhe, et al.
Publicado: (2020)

miR‐655 suppresses epithelial‐to‐mesenchymal transition by targeting Prrx1 in triple‐negative breast cancer
por: Lv, Zhi‐Dong, et al.
Publicado: (2016)

miR-100 Induces Epithelial-Mesenchymal Transition but Suppresses Tumorigenesis, Migration and Invasion
por: Chen, Dahu, et al.
Publicado: (2014)

Retracted: miR-381-3p Involves in Glioma Progression by Suppressing Tumor-Promoter Factor ANTXR1
por: Methods in Medicine, Computational and Mathematical
Publicado: (2023)

EZH2 Contributes To Cisplatin Resistance In Breast Cancer By Epigenetically Suppressing miR-381 Expression
por: Dou, Dongwei, et al.
Publicado: (2019)

Restoration of miR-1228* Expression Suppresses Epithelial-Mesenchymal Transition in Gastric Cancer
por: Jia, Litao, et al.
Publicado: (2013)

MiR-195 suppresses the metastasis and epithelial–mesenchymal transition of hepatocellular carcinoma by inhibiting YAP
por: Yu, Shuo, et al.
Publicado: (2017)

miR-381 suppresses C/EBPα-dependent Cx43 expression in breast cancer cells
por: Ming, Jia, et al.
Publicado: (2015)

miR-27b Suppresses Tongue Squamous Cell Carcinoma Epithelial–Mesenchymal Transition by Targeting ITGA5
por: Li, Tao, et al.
Publicado: (2020)

miR-146a-5p-mediated suppression on trophoblast cell progression and epithelial-mesenchymal transition in preeclampsia
por: Peng, Pingping, et al.
Publicado: (2021)

MiR-124 targets Slug to regulate epithelial–mesenchymal transition and metastasis of breast cancer
por: Liang, Yong-Jun, et al.
Publicado: (2013)

miR-136 targets MIEN1 and involves the metastasis of colon cancer by suppressing epithelial-to-mesenchymal transition
por: Ren, Haipeng, et al.
Publicado: (2017)

The PTTG1-targeting miRNAs miR-329, miR-300, miR-381, and miR-655 inhibit pituitary tumor cell tumorigenesis and are involved in a p53/PTTG1 regulation feedback loop
por: Liang, Hai-qian, et al.
Publicado: (2015)

MiR-363 suppresses cell migration, invasion, and epithelial-mesenchymal transition of osteosarcoma by binding to NOB1
por: Zhang, Yongtao, et al.
Publicado: (2020)

miR-145 and miR-497 suppress TGF-β-induced epithelial–mesenchymal transition of non-small cell lung cancer by targeting MTDH
por: Yin, Qi, et al.
Publicado: (2018)

Clinical significance of dysregulation of miR-381 in pediatric acute myeloid leukemia
por: Zhang, Piqiang, et al.
Publicado: (2020)

MiR‐30c protects diabetic nephropathy by suppressing epithelial‐to‐mesenchymal transition in db/db mice
por: Zhao, Yanru, et al.
Publicado: (2017)

SNHG15 Contributes To Cisplatin Resistance In Breast Cancer Through Sponging miR-381
por: Mi, Hailong, et al.
Publicado: (2020)

miR-381 functions as a tumor suppressor by targeting ETS1 in pancreatic cancer
por: Qiao, Guanen, et al.
Publicado: (2019)

Knockdown of SETDB1 inhibits breast cancer progression by miR-381-3p-related regulation
por: Wu, Milu, et al.
Publicado: (2018)

MiR-449a suppresses the epithelial-mesenchymal transition and metastasis of hepatocellular carcinoma by multiple targets
por: Chen, Shu-peng, et al.
Publicado: (2015)

MiR‐577 suppresses epithelial‐mesenchymal transition and metastasis of breast cancer by targeting Rab25
por: Yin, Chonggao, et al.
Publicado: (2018)

miR-10a suppresses colorectal cancer metastasis by modulating the epithelial-to-mesenchymal transition and anoikis
por: Liu, Yankun, et al.
Publicado: (2017)

MiR-381 functions as a tumor suppressor in colorectal cancer by targeting Twist1
por: He, Xinxin, et al.
Publicado: (2016)

miR-190 suppresses breast cancer metastasis by regulation of TGF-β-induced epithelial–mesenchymal transition
por: Yu, Yue, et al.
Publicado: (2018)

MiR-590-3p suppresses epithelial-mesenchymal transition in intrahepatic cholangiocarcinoma by inhibiting SIP1 expression
por: Zu, Chao, et al.
Publicado: (2017)

miR-381 Attenuates Peripheral Neuropathic Phenotype Caused by Overexpression of PMP22
por: Lee, Ji-Su, et al.
Publicado: (2019)

miR-486-5p suppresses prostate cancer metastasis by targeting Snail and regulating epithelial–mesenchymal transition
por: Zhang, Xiaoguang, et al.
Publicado: (2016)

MiR-199 Reverses the Resistance to Gemcitabine in Pancreatic Cancer by Suppressing Stemness through Regulating the Epithelial–Mesenchymal Transition
por: Wei, Weitian, et al.
Publicado: (2021)

miR-381 modulates human bone mesenchymal stromal cells (BMSCs) osteogenesis via suppressing Wnt signaling pathway during atrophic nonunion development
por: Long, Haitao, et al.
Publicado: (2019)

miR-381-3p Cooperated With Hes1 to Regulate the Proliferation and Differentiation of Retinal Progenitor Cells
por: Wang, Jiajing, et al.
Publicado: (2022)

Low expression of miR-381 is a favorite prognosis factor and enhances the chemosensitivity of osteosarcoma
por: Li, Yunchao, et al.
Publicado: (2016)

Puerarin inhibits hepatocellular carcinoma invasion and metastasis through miR-21-mediated PTEN/AKT signaling to suppress the epithelial-mesenchymal transition
por: Zhou, Yuan, et al.
Publicado: (2020)

Changes in the Expression of miR-381 and miR-495 Are Inversely Associated with the Expression of the MDR1 Gene and Development of Multi-Drug Resistance
por: Xu, Yan, et al.
Publicado: (2013)

miR-101 suppresses the epithelial-to-mesenchymal transition by targeting ZEB1 and ZEB2 in ovarian carcinoma
por: GUO, FEI, et al.
Publicado: (2014)

Targeting of AKT1 by miR-143-3p Suppresses Epithelial-to-Mesenchymal Transition in Prostate Cancer
por: Armstrong, Lee, et al.
Publicado: (2023)

miR-381 Inhibits Proliferation and Invasion of Non-Small-Cell Cancer Cells by Targeting USP39
por: Cui, Fang, et al.
Publicado: (2022)

miR-1207-5p suppresses laryngeal squamous cell carcinoma progression by downregulating SKA3 and inhibiting epithelial-mesenchymal transition
por: Wu, Yongyan, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_565p7uiit87c85k6mutc7tllai